Knocking down Siglec-15 in osteosarcoma cells inhibits proliferation while promoting apoptosis and pyroptosis by targeting the Siglec-15/STAT3/Bcl-2 pathway-Reference-Cited by-同舟云学术

Knocking down Siglec-15 in osteosarcoma cells inhibits proliferation while promoting apoptosis and pyroptosis by targeting the Siglec-15/STAT3/Bcl-2 pathway

Published:2022-09 Issue:2 Volume:67 Page:187-195
ISSN:1896-1126
Container-title:Advances in Medical Sciences
language:en
Short-container-title:Advances in Medical Sciences

Author:

Song Keliang^ORCID,Ma Jinfeng,Gao Yang,Qu Yan,Ren Chongmin,Yan Peng,Zheng Bingxin,Yue Bin

Publisher

Elsevier BV

Subject

General Medicine

Reference46 articles.

1. Osteosarcoma treatment – where do we stand? A state of the art review;Luetke;Cancer Treat Rev,2014

2. Pathology and genetics of tumours of soft tissue and bone;Folpe,2002

3. Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future;Chen;J Clin Invest,2015

4. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: mechanisms, response biomarkers, and combinations;Zou;Sci Transl Med,2016

5. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion;Dong;Nat Med,2002

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. tRF-33-P4R8YP9LON4VDP inhibits gastric cancer progression via modulating STAT3 signaling pathway in an AGO2-dependent manner;Oncogene;2024-05-23

2. The role of programmed cell death in osteosarcoma: From pathogenesis to therapy;Cancer Medicine;2024-05

3. Identification of therapeutic targets and prognostic biomarkers in the Siglec family of genes in tumor immune microenvironment of sarcoma;Scientific Reports;2024-01-05

4. Novel Siglec-15-Sia axis inhibitor leads to colorectal cancer cell death by targeting miR-6715b-3p and oncogenes;Frontiers in Immunology;2023-10-06

5. Unveiling and validation of a disulfidptosis determined prognostic model for osteosarcoma: new insights from prognosis to immunotherapy and chemotherapy;Oncologie;2023-06-07